Grandaxin

Medicinal product

(Invented) name

Grandaxin

Active substance (s)

Tofizopamas

Strength

50 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N05BA23, Tofisopam

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2025-09-05

Date of renewal

Documents

2842_Grandaxin 50mg N20 tablets_PL.docx

2842_Grandaxin 50mg N20 tablets_PZ.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Tofizopamas	50 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
118492	104596	1104596	lizdinė plokštelė	N20		Receptinis	LT/L/25/2842/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2025-09-05	Registruotas